Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              A Phase 1, Open-label, Single Center Study of KYV-101, an Autologous Fully-human Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects with Non-relapsing and Progressive Forms of Multiple Sclerosis

              Author:Dunn, Jeffrey   Galetta, Kristin   Tomczak, Anna   Timmons, Garrett   Ton-Nu, Crystal   Sumera, Julia   Martinez, Emma   Lowsky, Robert   

              Session Name:S3: Multiple Sclerosis: Clinical Trials  

              Topic:Multiple Sclerosis  

              Program Number:S3.001  

              Author Institution:Stanford University, Division of Neuroimmunology, Department of Neurology & Neurological Sciences, Palo Alto, CA  Stanford University, Blood, Marrow and Cellular Therapy Division, Stanford, CA  

              Comparing Brain MRI-derived Whole Brain and Grey Matter Volumes with Patient Reported Outcomes in a Cohort of People Living with MS

              Author:Timmons, Garrett   Tomczak, Anna   Dunn, Jeffrey   

              Session Name:P3: Multiple Sclerosis: Imaging of Demyelinating and Neuroinflammatory Diseases  

              Topic:Multiple Sclerosis  

              Program Number:P3.013  

              Author Institution:Stanford University, Palo Alto, CA